Global Stem Cell Market Size & CAGR (2021 to 2026)
The global stem cell market was valued at USD 16 166 million in 2021 and is expected to reach USD 29,028 million by the end of 2026, increasing at a CAGR of 12.42% during the projected period.
Impact of COVID-19 on the global stem cell market:
Coronavirus disease 2019 (COVID-19) is an acute respiratory infectious disease caused by the SARS coronavirus 2 (SARSCoV2). COVID-19, which mainly was unknown before the epidemic began in Wuhan (China) in December 2019, has quickly progressed from a regional issue to a global pandemic. On March 11, 2020, the World Health Organization (WHO) proclaimed COVID-19 a pandemic. To combat this pandemic, researchers have been developing novel cures and treatments. In recent years, stem cells have been an effective treatment for pulmonary illnesses such as COVID-19.
The pandemic of covid 19 has had a positive impact on the stem cell industry. The application of the product in the treatment of the new coronavirus has sparked interest in the medical community, increasing clinical trials. According to world meter statistics, the disease has a global prevalence of roughly 121 million as of March 17, 2021. Regenerative medicine based on cellular therapies may be a treatment option for patients, reducing death and infection rates. Companies and research institutes are collaborating to develop novel therapeutic solutions for the disease. For instance, in April 2020, the infectious illness Research Institute and cellularity, a New Jersey-based start-up, reported that the U.S. FDA had approved a clinical trial application to explore cell-based therapy for COVID-19.
Browse details of the report @ https://www.marketdataforecast.com/market-reports/global-stem-cell-market
KEY DRIVING FACTORS:
Increasing the prevalence of cardiovascular diseases and autoimmune disorders is are expected to accelerate the growth rate of the global stem cell market.
The growing frequency of cardiovascular illnesses is propelling the Stem Cell Market forward. Some of the critical risk factors for cardiovascular disease include a poor diet, tobacco use, and physical inactivity, raising blood pressure and blood glucose levels, resulting in overweight and obesity. According to the WHO, heart attacks and strokes account for four out of every five cardiovascular fatalities. In addition, the growing prevalence of autoimmune disorders is fueling the expansion of the Stem Cell Market. Autoimmune disease is an autoimmune disorder that destroys healthy cells, organs, and tissues. It can affect any portion of the body, impairing body function and posing a threat to one’s life. Women are far more prone than men to suffer autoimmune diseases. Furthermore, some disorders have no cure and, in some cases, require lifetime medication to alleviate symptoms. As a result, the Stem Cell Market is expected to rise during the projected period 2021-2026.
The intense focus of key players on collaborations and partnerships is likely to boost stem cell market growth.
The increased demand for cell-based therapies has hastened the need for product innovation and development. Growing technological breakthroughs have aided in the expansion of R&D, resulting in solid order and sales of the products. Key stakeholders are strategically working to increase R&D activities, increasing the number of clinical trials using cell-based approaches to examine therapy possibilities for complicated disorders. For instance, Evotec and Celgene Corporation formed a strategic alliance in June 2019 to expand the iPSCs technology collaboration to research and develop innovative neurodegenerative disease therapeutic options. In addition, Ecotec’s iPSC technology platform is one of the industry’s most advanced and large systems. As a result, such research collaborations are projected to fuel the expansion market during the forecast period.
RESTRAINING FACTORS:
Ethical concerns related to embryonic stem cells are acting as a retrain for the stem cell market.
As stem cells are created by killing the human embryo, several ethical concerns are involved with their use. Human embryos are seen as potential life, and eliminating them is considered unethical even if they can save a human life. Concerns about embryonic stem cells in the development of stem cell therapy are stifling global industry expansion.
Avail sample market brochure of the report to understand report usefulness, ask a copy @ https://www.marketdataforecast.com/market-reports/global-stem-cell-market/request-sample
KEY MARKET INSIGHTS:
- Based on treatment mode, the allogeneic therapy segment dominated with a revenue share of around 60.0% of the overall market in 2020. The allogeneic cell can make its immune cell, which suppresses cancer cell proliferation. Thus, it is used to prevent the spread of cancer. Furthermore, autologous stem cell therapy is expected to develop rapidly in the following years. Therefore, it is used to treat persons who have damaged bone marrow.
- Based on Cell Type, the adult stem cell segment is estimated to account for a reasonable share, expanding at a CAGR of over 12.5% from 2021 to 2026. The second highest market share is induced pluripotent stem cells, which are employed in research to uncover premature aging, congenital heart disease, and cancer. Regenerative medicine is also becoming more popular in the treatment of Alzheimer’s and Parkinson’s disease. As the number of cord cell preservations increases, so does the human embryonic stem cell segment.
- Asia Pacific is expected to increase at the fastest growth rate, registering a CAGR of around 14.0% from 2021 to 2026. With the increased instances of infection, the APAC Stem Cell Market will have good potential opportunities. In addition, the development of vaccines using diverse human diploid and non-tumorigenic cell lines is expected to increase market demand. Some of the factors predicted to fuel market expansion during the forecast period include ongoing research and the development of various illness vaccines.
- The stem cell market is very competitive, with several large firms. In terms of market share, the market is currently dominated by a few significant competitors. Significant market participants such as Thermo Fisher Scientific (Qiagen NV), Sigma Aldrich (a subsidiary of Merck KGaA), Becton, Dickinson and Company, and Stem Cell Technologies are growing market fierce competition. In addition, the significant businesses’ product advances and advancements in stem cell technologies are also generating competitive rivalry.
The report can be customized as per requirements; talk to our analyst team @ https://www.marketdataforecast.com/market-reports/global-stem-cell-market/customization
RECENT MARKET DEVELOPMENTS:
- In September 2020, Stemedica Cell Technologies gained investigational new drug (IND) approval from the U.S. Food and Drug Administration for intravenous allogeneic mesenchymal stem cells (MSCs) to treat moderate to severe pain.
- In August 2020, Pluristem Israel) worked with Abu Dhabi Stem Cells Center (UAE) to develop COVID-19 stem cell therapy.
- On May 6, 2020, The California Institute for Regenerative Medicine (CIRM) awarded Lineage Cell Therapeutics a USD 5 million grant to support the use of VAC, Lineage’s allogeneic dendritic cell treatment.
SEGMENTS COVERED IN THIS REPORT:
By Treatment Mode:
- Allogeneic
- Autologous
By Cells Type:
- Adult Stem Cells
- Induced Pluripotent Stem Cells
- Human Embryonic Stem Cells
- Others
By Technology:
- Cell Acquisition
- Cell Production
- Cryopreservation
- Other Sub-Segments
By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
KEY MARKET LEADERS PROFILED IN THIS REPORT:
- Athersys
- StemCells, Inc.
- Cryo Cell International
- Geron Corporation
- Mesoblast Ltd.
- Aastrom Biosciences, Inc.
- Celgene Corporation
- Invitrogen
- Cytori Therapeutics Inc.
BROWSE RELATED REPORTS:
- North America Stem Cell Market
- Europe Stem Cell Market
- APAC Stem Cell Market
- Latin America Stem Cell Market
- MEA Stem Cell Market
About MarketDataForecast:
Market Data Forecast is a firm working in market research, business intelligence, and consulting. We have rich research and consulting experience for various business domains to cater to individual and corporate clients’ needs.
Contact Us:
Market Data Forecast
Phone: +1-888-702-9626
Email: contact@marketdataforecast.com